2-[1-(2,2-dimethylpropyl)-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-5-yl]-4-{[1-phenyl-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl]methyl}benzonitrile | 1352423-21-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - Pyrroloazepines
• 英文名称: 2-[1-(2,2-dimethylpropyl)-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-5-yl]-4-{[1-phenyl-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl]methyl}benzonitrile
• 英文别名: 2-[1-(2,2-dimethylpropyl)-3-methyl-2-oxoimidazo[4,5-b]pyridin-5-yl]-4-[(1-phenyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)methyl]benzonitrile
• CAS: 1352423-21-2
• 化学式: C₃₃H₃₄N₆O
• 分子量: 530.673
• InChiKey: DONZVQYPMKZPGK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  40
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  68.4
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
  申请人：Arrington Kenneth L.

  公开号：US20130210768A1

  公开（公告）日：2013-08-15

  The present invention is directed to 5-substituted 1,3-dihydro-2H-imidazo[4,5-b]pyridine-2-one derivatives which are positive allosteric modulators of the mGluR2 receptor, useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved, such as schizophrenia.

  本发明涉及5-取代的1,3-二氢-2H-咪唑[4,5-b]吡啶-2-酮衍生物，它们是mGluR2受体的正向变构调节剂，可用于治疗或预防与谷氨酸功能障碍有关的神经和精神障碍以及涉及mGluR2受体的疾病。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及代谢型谷氨酸受体的疾病（如精神分裂症）中使用这些化合物和组合物的用途。
• US8765784B2
  申请人：——

  公开号：US8765784B2

  公开（公告）日：2014-07-01